1. Quick Detail
AMB-FUBINACA (also known as FUB-AMB and MMB-FUBINACA) is an
indazole-based synthetic cannabinoid that is a potent agonist of
the CB1 receptor and has been sold online as a designer drug.
It was originally developed by Pfizer which described the compound
in a patent in 2009, but was later abandoned and never tested on
Chemical and physical data
Molar mass: 383.42 g/mol
2. Company description
Dongmao Biotechnology Co., Limited specializes in exporting high
quality Research chemical, medical intermediate, Pharmaceutical
chemicals and so on.
Our products are produced on the basis of best technical team,
advanced equipment, high qualified management which meet the
requirements of security and environmental protection. We earned
customer trust and created a good reputation during these years. we are committed to provide the excellent quality of products and
the perfect services to the friends all over the world.
We will provide the most comprehensive products and service to you!
We are looking forward to your cooperation.